Clinical Trial Update: Can Thrombin Generation Measurement Predict the Risk of Venous Thromboembolism in Acute Ill Patients

View source ↗

Summary

A completed clinical trial evaluated thrombin generation measurement as a predictor of venous thromboembolism risk in acutely ill patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Venous Thromboembolism

Snippet

Sponsor: HaEmek Medical Center, Israel | Conditions: Venous Thromboembolism | Status: COMPLETED